Adoptive immunotherapy with recombinant interleukin 2, LAK and TIL.
Kurnick
J T
JT
Department of Pathology, Massachusetts General Hospital.
Kradin
R L
RL
D000818:Animals; D005069:Evaluation Studies as Topic; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000494:pharmacology / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000187:drug effects / Q000637:transplantation*; D016246:Lymphocytes, Tumor-Infiltrating / Q000637:transplantation*; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins